Survey of Naturally Occurring CD4+T Cell Responses against NY-ESO-1 in Cancer Patients: Correlation...
Survey of Naturally Occurring CD4+T Cell Responses against NY-ESO-1 in Cancer Patients: Correlation with Antibody Responses
About this item
Full title
Author / Creator
Publisher
United States: National Academy of Sciences
Journal title
Language
English
Formats
Publication information
Publisher
United States: National Academy of Sciences
Subjects
More information
Scope and Contents
Contents
NY-ESO-1 is one of the most immunogenic proteins described in human cancers, based on its capacity to elicit simultaneous antibody and CD8+T cell responses in vivo. Although HLA class II restricted epitopes from NY-ESO-1 have been identified, no broad survey has yet established the status of natural CD4+T cell responses in cancer patients in relati...
Alternative Titles
Full title
Survey of Naturally Occurring CD4+T Cell Responses against NY-ESO-1 in Cancer Patients: Correlation with Antibody Responses
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_crossref_primary_10_1073_pnas_1133324100
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1073_pnas_1133324100
Other Identifiers
ISSN
0027-8424
E-ISSN
1091-6490
DOI
10.1073/pnas.1133324100
